Tandlægeselskabet Wølund & Wolf ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  0.0% 3.9% 4.6% 7.1% 5.4%  
Credit score (0-100)  0 50 45 33 41  
Credit rating  N/A BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  0.0 7,578 6,913 7,611 8,136  
EBITDA  0.0 1,682 1,347 1,219 1,759  
EBIT  0.0 207 97.2 -46.6 494  
Pre-tax profit (PTP)  0.0 -564.4 -451.8 -675.5 -227.9  
Net earnings  0.0 -494.5 -352.5 -844.6 -227.9  
Pre-tax profit without non-rec. items  0.0 -564 -452 -675 -228  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  0.0 7,976 7,480 6,510 5,539  
Shareholders equity total  0.0 -455 -807 -1,652 -1,880  
Interest-bearing liabilities  0.0 13,185 13,479 12,652 11,811  
Balance sheet total (assets)  0.0 14,446 13,396 11,960 10,698  

Net Debt  0.0 12,874 13,474 12,634 11,776  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 7,578 6,913 7,611 8,136  
Gross profit growth  0.0% 0.0% -8.8% 10.1% 6.9%  
Employees  0 10 8 11 11  
Employee growth %  0.0% 0.0% -20.0% 37.5% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 14,446 13,396 11,960 10,698  
Balance sheet change%  0.0% 0.0% -7.3% -10.7% -10.6%  
Added value  0.0 1,682.3 1,346.7 1,202.9 1,758.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 12,022 -2,041 -2,530 -2,530  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 -1.0 1.0  

Profitability 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 2.7% 1.4% -0.6% 6.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 1.4% 0.8% -0.3% 3.8%  
ROI %  0.0% 1.6% 0.9% -0.4% 4.0%  
ROE %  0.0% -3.4% -2.5% -6.7% -2.0%  

Solidity 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  0.0% -3.1% -5.7% -12.2% -15.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 765.3% 1,000.5% 1,036.8% 669.6%  
Gearing %  0.0% -2,900.8% -1,670.3% -766.0% -628.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 11.8% 4.3% 4.8% 5.9%  

Liquidity 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.0 0.3 0.2 0.1 0.1  
Current Ratio  0.0 0.3 0.2 0.1 0.2  
Cash and cash equivalent  0.0 311.6 5.8 17.7 34.8  

Capital use efficiency 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -1,763.4 -2,648.8 -3,125.3 -2,933.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 168 168 109 160  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 168 168 111 160  
EBIT / employee  0 21 12 -4 45  
Net earnings / employee  0 -49 -44 -77 -21